Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
DiaMedica TherapeuticsDMAC | Open-market buy | 25/11/17–25/11/25 | 25/12/08 | 1,061,277 sh7 trades | $7.19avg. | $7,632,626.56 | +13.7% | |
DiaMedica TherapeuticsDMAC | Open-market buy | 25/08/13–25/08/27 | 25/09/04 | 1,000,000 sh9 trades | $5.96avg. | $5,958,598.39 | +14.8% | |
Richard Jacinto II10% Owner | DiaMedica TherapeuticsDMAC | Open-market buy | 25/07/23 | 25/07/25 | 400,000 sh | $3.50 | $1,400,000 | +8.8% |
Ab TomEnterprise10% Owner | DiaMedica TherapeuticsDMAC | Open-market buy | 25/07/23 | 25/07/25 | 2,857,142 sh | $3.50 | $9,999,997 | +51.7% |
Ab Trill10% Owner | DiaMedica TherapeuticsDMAC | Open-market buy | 25/07/23 | 25/07/25 | 1,542,857 sh | $3.50 | $5,399,999.5 | +29.5% |
Ab TomEnterprise10% Owner | DiaMedica TherapeuticsDMAC | Open-market buy | 24/06/28 | 24/07/01 | 1,200,000 sh | $2.50 | $3,000,000 | +27.7% |
Ab Trill10% Owner | DiaMedica TherapeuticsDMAC | Open-market buy | 24/06/28 | 24/07/01 | 1,200,000 sh | $2.50 | $3,000,000 | +29.8% |
David J. WambekeChief Business Officer | DiaMedica TherapeuticsDMAC | Open-market buy | 23/11/16 | 23/11/16 | 20,000 sh | $2.46 | $49,200 | +3.9% |
Ab TomEnterprise10% Owner | DiaMedica TherapeuticsDMAC | Open-market buy | 23/06/23 | 23/06/27 | 1,470,588 sh | $3.40 | $4,999,999.2 | +51.5% |
Scott KellenCFO and Secretary | DiaMedica TherapeuticsDMAC | Open-market buy | 23/06/23 | 23/06/26 | 10,000 sh | $3.91 | $39,100 | +44.9% |
Randall Michael GiuffreDirector | DiaMedica TherapeuticsDMAC | Open-market buy | 23/06/23 | 23/06/26 | 65,000 sh | $3.91 | $254,150 | +22.0% |
Richard D. PilnikDirector | DiaMedica TherapeuticsDMAC | Open-market buy | 23/06/23 | 23/06/26 | 38,363 sh | $3.91 | $149,999.33 | +18.3% |
Dietrich John PaulsPresident and CEO | DiaMedica TherapeuticsDMAC | Open-market buy | 23/06/23 | 23/06/26 | 12,787 sh | $3.91 | $49,997.17 | +22.9% |
Charles Pauling SembaDirector | DiaMedica TherapeuticsDMAC | Open-market buy | 23/06/23 | 23/06/26 | 12,787 sh | $3.91 | $49,997.17 | +74.5% |
David J. WambekeChief Business Officer | DiaMedica TherapeuticsDMAC | Open-market buy | 23/06/23 | 23/06/26 | 38,364 sh | $3.91 | $150,003.24 | +8.2% |
David J. WambekeChief Business Officer | DiaMedica TherapeuticsDMAC | Open-market buy | 23/04/10 | 23/04/11 | 468,750 sh | $1.60 | $750,000 | No record |